共 50 条
- [23] Toxic epidermal necrolysis due to ipilimumab and nivolumab in a patient with metastatic melanoma [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2021, 74 (03): : 294 - 297
- [24] Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S934 - S934
- [27] Nivolumab (Opdivo) for Metastatic Melanoma and Metastatic NSCLC [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1470): : 85 - 87
- [28] Immune checkpoint inhibitor-related gastritis in a patient with metastatic melanoma [J]. JGH OPEN, 2021, 5 (10): : 1218 - 1219
- [29] Immune-Related Pancreatitis Secondary to Ipilimumab and Nivolumab in a Patient With Melanoma [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S686 - S686
- [30] Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2177 - 2178